home / stock / bblg / bblg short
Short Information | Bone Biologics Corp (OTCMKTS:BBLG)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 66,165 |
Total Actual Volume | 79,870 |
Short Trends | |
---|---|
Cover Days | 7 |
Short Days | 12 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 3,308 |
Average Short Percentage | 59.63% |
Is there a BBLG Short Squeeze or Breakout about to happen?
See the BBLG Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
11-25-2020 | $5.25 | $5.25 | $5.25 | $5.25 | 200 | 100 | 50% |
11-02-2020 | $3 | $4.85 | $5 | $3 | 700 | 200 | 28.57% |
07-13-2018 | $2.60 | $3.00 | $3.00 | $2.60 | 300 | 100 | 33.33% |
07-05-2018 | $2.38 | $2.50 | $2.50 | $2.38 | 1,200 | 200 | 16.67% |
06-25-2018 | $2.00 | $2.00 | $2.00 | $2.00 | 200 | 100 | 50% |
05-21-2018 | $2.25 | $2.25 | $2.25 | $2.25 | 100 | 100 | 100% |
04-27-2018 | $1.85 | $2.00 | $2.00 | $1.85 | 2,950 | 50 | 1.69% |
04-24-2018 | $2.14 | $1.00 | $2.14 | $1.00 | 3,050 | 2,205 | 72.3% |
04-10-2018 | $N/A | $2.99 | $N/A | $N/A | 20 | 20 | 100% |
04-05-2018 | $2.10 | $2.99 | $2.99 | $2.10 | 2,600 | 2,500 | 96.15% |
04-02-2018 | $1.76 | $1.76 | $1.76 | $1.76 | 145 | 40 | 27.59% |
03-29-2018 | $2.99 | $2.99 | $3.00 | $2.99 | 1,000 | 500 | 50% |
03-13-2018 | $2.15 | $2.02 | $2.15 | $2.02 | 14,850 | 14,550 | 97.98% |
03-12-2018 | $2.15 | $2.15 | $2.15 | $2.15 | 10,000 | 10,000 | 100% |
03-09-2018 | $1.00 | $1.97 | $1.98 | $1.00 | 2,800 | 200 | 7.14% |
02-22-2018 | $0.90 | $1.154 | $1.154 | $0.90 | 29,300 | 29,100 | 99.32% |
02-16-2018 | $1.00 | $1.34 | $1.35 | $0.90 | 3,100 | 600 | 19.35% |
02-09-2018 | $1.25 | $1.40 | $1.40 | $1.25 | 1,000 | 1,000 | 100% |
02-01-2018 | $1.00 | $1.00 | $1.00 | $1.00 | 3,005 | 1,500 | 49.92% |
01-31-2018 | $1.00 | $1.00 | $1.50 | $1.00 | 3,350 | 3,100 | 92.54% |
News, Short Squeeze, Breakout and More Instantly...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW) , a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced public offering of an aggregate of 781,251 shares of its com...
Shares of BioVie Inc. (NASDAQ: BIVI) fell sharply in today’s pre-market trading after the company reported pricing of public offering. BioV...
Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced the pricing of its public offering of an aggregate of 781,251 shares of its common stock (or common sto...